RESUMO
The present study was the first approach conducted under environmental concentrations of Gd-DOTA and Gd-DTPA-BMA to assess cellular impacts of these compounds. Gd-DOTA (Gadoteric acid) is one of the most stable contrast agent, currently used as Dotarem® formulation during Magnetic Resonance Imaging exams. The study was mainly performed on a Zebra Fish cell line (ZF4; ATCC CRL-2050). At the concentrations of 0.127â¯nM and 63.59â¯nM (respectively 20â¯ng and 10⯵g of Gd/L), we did not observed any toxicity of Dotarem® but a slowdown of the cell growth was clearly measured. The effect is independent of medium renewing during 6 days of cell culturing. The same effect was observed i-with Gd-DOTA on another fish cell line (RT W1 gills; ATCC CRL-2523) and ii-with another contrast agent (Gd-DTPA-BMA - Omniscan®) on ZF4 cells. On the ZF4 cell line, the diminution of the cell growth was of the same order during 20 days of exposure to a culture medium spiked with 63.59â¯nM of Dotarem® and was reversible within the following 8 days when Dotarem® was removed from the medium. As shown by using modified DOTA structure (Zn-DOTA), the effect may be due to the chelating structure of the contrast agent rather than to the Gd ion. Until now, the main attention concerning the impact of Gd-CA on living cells concerned the hazard due to Gd release. According to our results, quantifying the presence of Gd-CA chelating structures in aquatic environments must be also monitored.
Assuntos
Meios de Contraste/toxicidade , Gadolínio DTPA/toxicidade , Compostos Heterocíclicos/toxicidade , Meglumina/toxicidade , Compostos Organometálicos/toxicidade , Poluentes Químicos da Água/toxicidade , Animais , Biomarcadores/análise , Ciclo Celular/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Quelantes , Imageamento por Ressonância Magnética , Oncorhynchus mykiss , Peixe-ZebraRESUMO
Fever can be elicited in the rabbit by the intravenous administration of relatively large doses of a synthetic immunoadjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide (MDP). This response could be mediated by endogenous pyrogen because MDP has been shown to induce their production both in vivo and in vitro. The results reported here show that intracisternal injection of minute amounts of MDP could elevate fever without activating the release of endogenous pyrogen in the plasma or in the cerebrospinal fluid. Moreover, indomethacin inhibited hyperthermia produced by intracerebroventricular administration of MDP. Therefore, our findings argue in favor of a direct effect of the glycopeptide on the thermoregulatory centers besides its indirect effect through the production of leukocytic pyrogen. This molecule apparently represents the minimal requirement for the pyrogenicity of bacterial peptidoglycan because administration, even by the intracerebral route, of a mixture of muramic acid and of its dipeptide moiety did not elicit fever.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Encéfalo/efeitos dos fármacos , Febre/induzido quimicamente , Glicopeptídeos/farmacologia , Animais , Regulação da Temperatura Corporal/efeitos dos fármacos , Infusões Parenterais , Injeções Intraventriculares , Masculino , Pirogênios/metabolismo , CoelhosRESUMO
We present evidence that toxic shock syndrome toxin 1 (TSST-1) induces the production of high levels of TNF by human blood monocytes. Enriched lymphocyte preparations incubated with the staphylococcal toxin produced significant levels of TNF-like activity that is not neutralized by anti-rHuTNF antibodies and is likely to be lymphotoxin (LT or TNF-beta). We demonstrate also that TSST-1 is a potent inducer of IFN-gamma. When lymphocyte preparations were costimulated with PMA, the TSST-1 effect was strongly potentiated and the levels of cytotoxic factors, IFN-gamma, and IL-2 present in supernatant fluids were comparable to those observed after treatment with PMA and PHA. Thus, TSST-1, which is also known as an inducer of IL-1 and IL-2, stimulates the production of endogenous mediators that could play a role in the physiopathological processes of toxic shock syndrome (TSS). The described results suggest that the discrepancies in the clinical features between TSS and endotoxin shock may be related to qualitative differences in cytokine production.
Assuntos
Toxinas Bacterianas , Enterotoxinas/farmacologia , Interferon gama/biossíntese , Superantígenos , Fator de Necrose Tumoral alfa/biossíntese , Anticorpos/imunologia , Citotoxicidade Imunológica , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Leucócitos Mononucleares/patologia , Linfócitos/patologia , Staphylococcus aureus , Fator de Necrose Tumoral alfa/imunologiaRESUMO
Gram-negative vaccines can elicit the production of tumor necrosis factor (TNF) in mice primed by muramyl dipeptide (MDP) or by its lipophilic derivative MDP-dipalmitoyl glycerol (MDP-GDP). In mice pretreated with MDP and particularly with MDP-GDP, Bordetella pertussis vaccine was shown to be more effective than typhoid vaccine. The time course of TNF production in the blood did not indicate any difference between the effect of MDP or of MDP-GDP. In both cases the cytotoxic activity reached maximal levels by 2 h after injection of the bacterial preparations and returned to normal values between 3 and 5 h after the challenge. In nude mice, high titers of circulating TNF were also produced by combined treatment with MDP-GDP and bacterial vaccine. Moreover, in tumor-bearing mice the association of MDP or of MDP-GDP to a bacterial vaccine induced a strong hemorrhagic necrosis, whereas each treatment alone was inactive. It was also found that mice were less sick when they were primed with MDP-GDP than with MDP, and when TNF was elicited by B. pertussis instead of lipopolysaccharide. Moreover, nude mice appeared more resistant to shock and to hemoconcentration than normal mice.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Vacinas Bacterianas/farmacologia , Fator de Necrose Tumoral alfa/biossíntese , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Animais , Lipopolissacarídeos/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Vacina contra Coqueluche/farmacologia , Fatores de Tempo , Triglicerídeos/farmacologia , Vacinas Tíficas-Paratíficas/farmacologiaRESUMO
Muramyl dipeptide (MDP) is a small molecular weight synthetic glycopeptide (less than 500), which has been shown to be an immunoadjuvant, and to induce a biphasic febrile response in the rabbit--probably via the release of endogenous pyrogen--accompanied by a marked leukopenia. Macromolecularization by coupling to a synthetic carrier (MW approximately or equal to 60,000) potentiates the immunostimulant properties of MDP but also its pyrogenicity. The present study demonstrates that such a conjugate induced the release of endogenous pyrogen in vivo and in vitro at lower dosage levels than free MDP. Further experiments showed that there existed several differences between free and conjugated MDP. Thus, after intravenous administration of the conjugate, the fever pattern was monophasic with a prompt defervescence and not accompanied by leukopenia at dosage levels inducing similar increase in body temperature. In addition, when fever was recorded after intracerebroventricular administration, the increase in sensitivity was much greater in the case of free MDP than of MDP-A--L.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/toxicidade , Adjuvantes Imunológicos , Febre/fisiopatologia , Pirogênios , Animais , Células Cultivadas , Febre/induzido quimicamente , Injeções Intraventriculares , Peptídeos e Proteínas de Sinalização Intercelular , Contagem de Leucócitos , Lipopolissacarídeos/toxicidade , Masculino , Peptídeos , Polimixina B/farmacologia , CoelhosRESUMO
Lipopolysaccharide-induced necrosis of grafted tumors was potentiated by several hydrophilic and lipophilic muramyl dipeptide (MDP) derivatives administered a few hours prior to small amounts of lipopolysaccharide (LPS) in spite of low titers of induced circulating tumor necrosis factor (TNF). However, pretreatment with MDP derivatives did increase the level of TNF in the blood of mice challenged by a greater dose of LPS. The TNF amount in 2 h postendotoxin mouse serum reached a peak when the glycopeptide had been given 6 h before the challenge, being approximately 100-fold above that obtained in unprimed mice. The cytotoxic activity in mouse serum was inhibited by rabbit antibodies raised against recombinant mouse TNF. Although there exists a toxic synergism between BCG or MDP and endotoxin, the effect of certain MDP derivatives was not related to an increased susceptibility to the toxicity of LPS.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Lipopolissacarídeos/farmacologia , Fator de Necrose Tumoral alfa/metabolismo , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Acetilmuramil-Alanil-Isoglutamina/toxicidade , Animais , Sinergismo Farmacológico , Feminino , Lipopolissacarídeos/toxicidade , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Fator de Necrose Tumoral alfa/toxicidadeRESUMO
Muramyl dipeptide (MDP) and adjuvant-active derivatives were confirmed as unable directly to induce differentiation of mouse myeloid leukemia M1 cells. They were, however, found effective in stimulating either rabbit macrophages or human blood monocytes to produce differentiation-stimulating activity (D factor). The various conditioned media (CM) thus obtained were able to induce differentiation of the myeloblastic M1 cell line as indicated by the appearance of Fc receptors and inhibition of cell proliferation. Among the synthetic glycopeptides inducing the production of D factor, murabutide (MDP[Gln]-OnBu) was as effective as MDP, although it did not stimulate monocytes to simultaneously release endogenous pyrogen. The absence of pyrogenicity in murabutide CM was attested by IV or intracerebroventricular administration to rabbits. However, in the same CM, LAF(IL1) activity estimated by potentiation of the in vitro proliferative response to phytohemagglutinin of mouse thymocytes was usually higher than that induced by MDP.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Transformação Celular Neoplásica , Glicoproteínas/biossíntese , Inibidores do Crescimento , Interleucina-6 , Leucemia Mieloide Aguda/patologia , Linfocinas , Monócitos/metabolismo , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Animais , Linhagem Celular , Transformação Celular Neoplásica/efeitos dos fármacos , Meios de Cultura , Humanos , Interleucina-1/fisiologia , Fator Inibidor de Leucemia , Ativação de Macrófagos , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos DBA , Monócitos/imunologia , Pirogênios/farmacologia , CoelhosRESUMO
Protein kinase C activity of the human myeloma cell line, RPMI 8226, was studied after prepurification on DEAE-cellulose. The total protein kinase activity, eluted at 0.12 M NaCl, was 493 nmol/min/10(10) cells, but 38% was associated with membranes. The lipid dependence of cytosolic and membrane activities was only 52% and 21%, respectively. This activity increased with time, to as much as 200% for the membrane fraction after 7 days, whereas lipid dependence and the PDBu binding properties were lost. This modified activity was not due to the extinction of a copurifying endogenous inhibitor nor to classical PKC proteolysis. TPA-treatment of these cels is accompanied by a rapid, selective and complete loss of lipid-dependent activity of the cytosol, thus benefiting co-migrating lipid independent activity, with no membrane fraction recovery or PKM formation.
Assuntos
Proteína Quinase C/metabolismo , Animais , Encéfalo/enzimologia , Fracionamento Celular , Linhagem Celular , Membrana Celular/enzimologia , Cromatografia DEAE-Celulose , Citosol/enzimologia , Humanos , Cinética , Mieloma Múltiplo/enzimologia , Dibutirato de 12,13-Forbol/metabolismo , Ligação Proteica , Proteína Quinase C/isolamento & purificação , Ratos , Acetato de Tetradecanoilforbol/farmacologia , Fatores de TempoRESUMO
Apolipoproteins A-II and C-III, which participate in the control of cholesterolemia and triglyceridemia, are negative acute phase proteins. Treatment of HepG2 cells with TNFalpha showed that apoA-II and apoC-III mRNA levels were decreased. Using transient transfection, we found that apoC-III gene expression is controlled at the transcriptional level. By competition and supershift experiments, we demonstrate that TNFalpha-induced complexes were related to C/EBPdelta/NF-IL6beta and p50 and that overexpression of C/EBPdelta was able to reproduce the inhibitory effect of TNFalpha on the apoC-III promoter. RT-PCR failed to detect the IL-1 transcript in TNFalpha-treated HepG2 cells, suggesting that activation of C/EBPdelta by TNFalpha is not related to the IL-1-signalling pathway.
Assuntos
Apolipoproteínas C/genética , Proteínas Estimuladoras de Ligação a CCAAT , Proteínas de Ligação a DNA/metabolismo , Regulação Neoplásica da Expressão Gênica , Interleucina-1/metabolismo , Proteínas Nucleares/metabolismo , Fatores de Transcrição/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Apolipoproteína A-II/genética , Apolipoproteína A-II/metabolismo , Apolipoproteína C-III , Apolipoproteínas C/metabolismo , Proteína delta de Ligação ao Facilitador CCAAT , Carcinoma Hepatocelular , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Proteínas de Ligação a DNA/genética , Humanos , NF-kappa B/genética , NF-kappa B/metabolismo , Subunidade p50 de NF-kappa B , Proteínas Nucleares/genética , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Fatores de Transcrição/genética , Transcrição Gênica , Transfecção , Células Tumorais CultivadasRESUMO
Cyclosporin A (CsA) administration reduced mortality in mice sensitized to endotoxic toxicity by various agents, such as muramyl dipeptide (MDP) or a lipophilic derivative. CsA is an inhibitor of a variety of T cell responses, suggesting that muramyl peptides could influence LPS-induced effects via the release of lymphokine. The potentiation of TNF production by pretreatment with muramyl peptides was comparable in nude mice and in controls, indicating that it is a T-independent mechanism, and CsA produced a similar inhibition in both groups. Neutralizing antibody to IFN-gamma did not change the elevated TNF level obtained in the blood when LPS was given after a muramyl peptide. However, the same treatment with anti-IFN-gamma MAb prevented the death of mice challenged with LPS plus MDP or plus a lipophilic derivative displaying similar effects. In comparing three selected muramyl peptides, we also show that the priming effect could be dissociated from the toxic synergism with LPS.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Ciclosporina/farmacologia , Interferon gama/fisiologia , Lipopolissacarídeos/farmacologia , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais , Sinergismo Farmacológico , Feminino , Interferon gama/imunologia , Interleucina-6/biossíntese , Camundongos , Camundongos Endogâmicos , Camundongos Nus , Dados de Sequência Molecular , Taxa de Sobrevida , Fator de Necrose Tumoral alfa/biossínteseRESUMO
Lipopolysaccharide (LPS) is a well known interleukin-1 inducer. Polymyxin B sulphate (PMB) is a cyclic antibiotic which neutralizes different biological properties of LPS. Under the conditions used in our laboratory, we were able to show that PMB alone could stimulate human monocytes to produce and release interleukin-1 activity, and that PMB was unable to inhibit the production of interleukin-1 by human monocytes stimulated with LPS. On the contrary, a synergistic effect was obtained which was not observed with another stimulant such as muramyl dipeptide.
Assuntos
Interleucina-1/biossíntese , Polimixina B/farmacologia , Polimixinas/farmacologia , Acetilmuramil-Alanil-Isoglutamina/farmacologia , Células Cultivadas , Sinergismo Farmacológico , Humanos , Lipopolissacarídeos/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Linfócitos/imunologia , Linfócitos/metabolismo , Frações Subcelulares/análiseRESUMO
Adjuvant muramyl dipeptides enhanced the intracellular oxidative burst induced by phorbol myristate acetate in purified human polymorphonuclear (PMN) cells and in monocytes. A stronger priming effect was obtained when muramyl dipeptide was conjugated to a protein carrier. Recombinant human tumor necrosis factor (TNF) did not modify the level of intracellular NBT reduction in PMA-stimulated PMN, although it slightly increased the secretion of superoxide anion. In contrast, TNF enhanced the intracellular oxidative burst of monocytes even at the concentration of 10 pg/ml. In human PMN only, the combination of TNF and muramyl dipeptide induced a higher oxidative response than each stimulant alone.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Fagócitos/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia , Grupo dos Citocromos c/metabolismo , Humanos , Técnicas In Vitro , Lipopolissacarídeos/farmacologia , Monócitos/metabolismo , Neutrófilos/metabolismo , Nitroazul de Tetrazólio/metabolismo , Oxirredução , Fagócitos/metabolismo , Proteínas Recombinantes , Acetato de Tetradecanoilforbol/farmacologiaRESUMO
The murine pre-B cell line 70Z/3 responds to lipopolysaccharide (LPS), interleukin-1 (IL-1) or interferon-gamma (IGN gamma) by kappa gene transcription and expression of surface IgM (sIg). We found that muramyl dipeptide (MDP), a synthetic immunoadjuvant analog of a bacterial membrane structure, produced a weak increase in the number of sIg-positive 70Z/3 cells as measured by immunofluorescence staining. This number was significantly increased after exposure to MDP. Moreover, when MDP was used in combination with LPS, IL-1 or IFN gamma, an enhancement of sIg expression was observed showing an early influence of MDP in the presence of a second stimulant. Unexpectedly, two adjuvant-active analogs of MDP did not share its capacity to stimulate differentiation of the cell line when used alone or associated with other agents, indicating that adjuvanticity of MDP was not the only requirement. Two other products of bacterial origin, a Staphylococcus aureus cell extract (SAC) and the Toxic Shock Syndrome Toxin TSST-1 could neither enhance the kappa gene expression in 70Z/3 cells nor increase the MDP effect. The stimulating effect displayed by MDP could by related to NF-kappa B activation.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Linfócitos B/efeitos dos fármacos , Receptores de Antígenos de Linfócitos B/efeitos dos fármacos , Animais , Linfócitos B/imunologia , Linhagem Celular , Cadeias kappa de Imunoglobulina/efeitos dos fármacos , Interferon gama/efeitos dos fármacos , Interferon gama/fisiologia , Interleucina-1/fisiologia , Lipopolissacarídeos/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Camundongos , Receptores de Antígenos de Linfócitos B/biossíntese , Células-Tronco/efeitos dos fármacos , Células-Tronco/imunologiaRESUMO
Innate and acquired resistance to Klebsiella pneumoniae infection were investigated in high (HI) and low (LI) antibody responder lines of mice. The two lines were very susceptible to infection since even small inoculum doses of a virulent strain provoked a 100% mortality within a few days. However the mean survival time was significantly longer in LI than in HI. (HI X LI) F1 hybrids were more resistant than both parental lines. Immunization with heat killed K. pneumoniae was able to confer full protection on the mice in the two lines. However there was a large difference in the number of killed bacteria required to induce the protective effect in HI and in LI mice. The dose-effect relationship for protection correlated with that of antibody production. The protective role of antibodies was confirmed by the survival of HI and LI mice, when antibodies were passively given prior to lethal challenge. The results are in agreement with the fact already demonstrated, that the defect of LI mice in antibody responsiveness is a quantitative one. Therefore a satisfactory immune protection against K. pneumoniae could be obtained in LI mice by adapting the vaccination procedure.
Assuntos
Anticorpos Antibacterianos/genética , Vacinas Bacterianas/imunologia , Infecções por Klebsiella/imunologia , Animais , Relação Dose-Resposta Imunológica , Feminino , Imunidade Inata , Imunização Passiva , Infecções por Klebsiella/prevenção & controle , Klebsiella pneumoniae , Masculino , CamundongosRESUMO
L2C B lymphocytes have a constant high DNA synthesis due to their continuous proliferative state. The addition of polymyxin B (PmB), a rather selective inhibitor of protein kinase C, stopped (3H)thymidine incorporation with an IC50 of 10 microM when added 18 h before measuring DNA synthesis. Interestingly, PmB inhibition of DNA synthesis was suppressed when 4 nM 12-O-tetradecanoylphorbol-13-acetate was added along with PmB, indicating that PmB may act through inhibition of protein kinase C. In the node and spleen lymphocytes of normal guinea pigs, protein kinase C activity was entirely cytosolic and was eluted at 0.12 M NaCl when adsorbed on DEAE-cellulose. In L2C leukemic lymphocytes, total protein kinase C activity was of the same order of magnitude, but 20% of it was associated with the membrane fraction. The lipid-dependent activity, eluted at 0.12 M NaCl from cytosolic and membrane fractions, was suppressed by staurosporine with an IC50 of 10-40 nM and by polymyxin B with an IC50 of 2-6 microM. Phosphoinositide metabolism was studied in the transformed cells. Incorporation of 32Pi into polyphosphoinositides was considerable, whereas much more time was required for a tiny incorporation of inositol. We detected no release of radioactive inositol triphosphate. Taken together, these results suggest that protein kinase C function is indispensible for triggering L2C leukemic lymphocyte proliferation. The causes of this permanent activation merit further investigation.
Assuntos
Linfócitos B/metabolismo , Linfoma de Burkitt/metabolismo , DNA/biossíntese , Fosfatidilinositóis/metabolismo , Proteína Quinase C/metabolismo , Animais , Linfócitos B/enzimologia , Linfoma de Burkitt/enzimologia , Linfoma de Burkitt/genética , Linhagem Celular , Cromatografia DEAE-Celulose , AMP Cíclico/antagonistas & inibidores , Ativação Enzimática , Feminino , Cobaias , Hidrólise , Ácidos Fosfatídicos/biossíntese , Fosfatidilinositol 4,5-Difosfato , Fosfatidilinositóis/biossíntese , Fosfolipídeos/análise , Proteína Quinase C/antagonistas & inibidores , Células Tumorais Cultivadas/enzimologia , Células Tumorais Cultivadas/metabolismoRESUMO
In the presence of the adjuvant glycopeptide muramyl dipeptide (MDP), purified human PMN exhibited an enhanced capacity to kill Candida albicans cells at various cell ratios. A significant effect was obtained at 100 ng/ml MDP, and the maximum was reached at 1 micrograms/ml MDP. Recombinant human tumor necrosis factor (rHuTNF), a monokine that enhances host resistance to bacterial and fungal infections, also stimulated the candidacidal potency of PMN with a maximal effect at 10(-2) ng/ml rHuTNF. When MDP- or rHuTNF-stimulated PMN were cultured with yeast cells, the intracellular production of oxygen metabolites was enhanced. Pretreatment with inhibitors of oxidative burst demonstrated that the yeast cell killing by MDP-stimulated PMN was not affected by SOD but was inhibited by sodium azide, indicating the involvement of myeloperoxidase (MPO)-halide system in fungicidal mechanisms induced by MDP. When PMN were stimulated with rHuTNF, the killing of yeast cells was neutralized by iodoacetamide, showing that the candidacidal potency of stimulated-PMN was due to oxygen derivatives. Inhibition by sodium azide and sodium benzoate indicated that these oxygen metabolites could be derived from the MPO-halide system but also from hydroxyl radical production. Moreover, SOD partially inhibited the fungicidal potency of rHuTNF-stimulated PMN, thus indicating a possible reutilization of the released O2- anion for intracellular killing. Cytochalasin B abrogated the PMN fungicidal potency in all cases.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Candida albicans/imunologia , Neutrófilos/imunologia , Oxigênio/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Células Cultivadas , Citocalasina B/farmacologia , Grupo dos Citocromos c/metabolismo , Humanos , Neutrófilos/metabolismo , Nitroazul de Tetrazólio/metabolismo , Fagocitose , Proteínas Recombinantes , Saccharomyces cerevisiae/metabolismo , Superóxido Dismutase/farmacologia , Acetato de Tetradecanoilforbol/farmacologiaRESUMO
A selective inhibition of LPS-induced tumor necrosis factor-alpha (TNF) response in mice was caused by an injection of recombinant human interleukin-1 (IL-1). The decrease in serum TNF level reached 70 to 80 percent of the controls receiving LPS alone when IL-1 was given simultaneously or prior to the challenge. At the same time serum IL-6 release was more elevated. Ex vivo assays have shown that macrophages from IL-1 treated animals did not respond to LPS when stimulated immediately after harvesting but recovered their normal responsiveness after being cultured for 2 hours and then washed. In vitro with or without addition of IL-1, mouse elicited macrophages responded equally to LPS in releasing TNF. In the absence of a direct and lasting effect on TNF-producing cells, the host reaction responsible for the inhibitory effect of IL-1 could be related to the overproduction of corticosterone that occurred after IL-1 injection, since it was not observed in adrenalectomized animals. Indeed the blockade of corticoid secretion by indomethacin prevented the inhibition of TNF production induced by IL-1 administration before LPS challenge. TNF administration did not result in elevation of corticosterone level and in contrast to IL-1 enhanced the TNF response to LPS injection. In vitro and ex vivo assays have shown this enhanced response to LPS was linked to a direct and prolonged effect of TNF on TNF-producing cells. Muramyl dipeptide (MDP) which was used as a known priming agent for enhanced cytokine release had a similar effect on TNF-producing cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Regulação para Baixo/efeitos dos fármacos , Interleucina-1/farmacologia , Fator de Necrose Tumoral alfa/biossíntese , Acetilmuramil-Alanil-Isoglutamina/farmacologia , Glândulas Suprarrenais/metabolismo , Adrenalectomia , Animais , Corticosterona/sangue , Dexametasona/farmacologia , Feminino , Vida Livre de Germes , Indometacina/farmacologia , Interleucina-6/biossíntese , Lipopolissacarídeos/imunologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , Proteínas Recombinantes/farmacologia , Fatores de Tempo , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
Muramyl dipeptide (MDP) induces NF-kappa B activation in the murine pre-B cell line 70Z/3, increases the expression of surface immunoglobulins, and potentiates the response to other inducers such as LPS or IL-1. In the present study we investigated whether NF-kappa B activation was related to the MDP-stimulated immunoglobulin expression. In a gel shift assay our results confirmed that MDP but not MDP(D,D), an adjuvant-inactive stereoisomer, could induce a kappa B-binding activity in 70Z/3 cells. The LPS or IL-1 induced NF-kappa B binding activity was increased in the presence of MDP but not of MDP(D,D). A mutant of the cell line called 1.3E2, defective in NF-kappa B activations by LPS, did not respond to MDP. The enhanced surface immunoglobulin expression induced in the wild type 70Z/3 cells by MDP alone or combined to LPS, IL-1 or IFN gamma was not obtained in this variant. The ability of various treatments to activate the kappa gene enhancer was quantitatively evaluated in cells transfected with a kappa-enhancer-luciferase expression plasmid. Treatment of transfected 70Z/3 cells with MDP resulted in a dose-dependent enhancement of luciferase activity, an additive effect to that induced by LPS or IL-1. Treatment of the defective variant transfected with the same construct did not result in luciferase expression after stimulation with the various agents. The transient transfection assays were used to compare the effectiveness of some MDP analogs. Two adjuvant-active compounds unable to enhance kappa light chain expression did not increase the basal response in the transfected 70Z/3 cells, indicating that NF-kappa B activation was not related to the adjuvant potency of MDP but correlated with the kappa induction.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Linfócitos B/imunologia , NF-kappa B/fisiologia , Células-Tronco/imunologia , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Animais , Linfócitos B/citologia , Linfócitos B/efeitos dos fármacos , Sequência de Bases , Diferenciação Celular/imunologia , Linhagem Celular , Citometria de Fluxo , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/imunologia , Variação Genética/imunologia , Luciferases/efeitos dos fármacos , Camundongos , Dados de Sequência Molecular , Mutação/imunologia , NF-kappa B/efeitos dos fármacos , NF-kappa B/genética , Ligação Proteica/efeitos dos fármacos , Receptores de Antígenos de Linfócitos B/análise , Células-Tronco/citologia , Células-Tronco/efeitos dos fármacos , TransfecçãoRESUMO
The effect of cyclosporin A (CsA) on tumor necrosis factor (TNF) or interleukin-6 (IL-6) production was evaluated in vivo in primed or unprimed mice challenged with lipopolysaccharide (LPS). Both pretreatment with BCG infection or with muramyl dipeptide (MDP) prior to LPS challenge resulted in an increase in the cytokine bioactivity level in the blood. CsA administration inhibited the TNF production. In unprimed mice, either normal or sensitized to LPS lethality by galactosamine treatment, a marked decrease in the cytokine level was observed after injection of CsA. After adrenalectomy, the yield of both TNF and IL-6 following LPS injection was markedly elevated but decreased by CsA administration. Ex vivo experiments have shown that the inhibitory effect of CsA could be demonstrated at the level of macrophages from mice previously given the drug. If mice had received MDP, in vitro responses of cells to LPS were enhanced but again CsA decreased the mRNA expression and protein secretion.
Assuntos
Acetilmuramil-Alanil-Isoglutamina/farmacologia , Toxinas Bacterianas/farmacologia , Ciclosporina/farmacologia , Endotoxinas/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Imunossupressores/farmacologia , Interleucina-6/biossíntese , Lipopolissacarídeos/farmacologia , Fator de Necrose Tumoral alfa/biossíntese , Adrenalectomia , Animais , Ciclosporina/uso terapêutico , Interações Medicamentosas , Feminino , Galactosamina/farmacologia , Imunossupressores/uso terapêutico , Macrófagos/efeitos dos fármacos , Macrófagos/fisiologia , Camundongos , Mycobacterium bovis/imunologia , Organismos Livres de Patógenos Específicos , Tuberculose/imunologiaRESUMO
Serum from BCG-infected mice that receive a lethal dose of LPS induces necrosis of a variety of transplanted mouse tumors. This serum (TNS) was shown to protect mice against two types of infectious challenges, Klebsiella and Listeria organisms. The antimicrobial activity was also demonstrated in adult C3H/He mice and in newborn mice, which are known to be refractory to the LPS-mediated increase in nonspecific resistance to infections.